Trial Profile
Open label clinical study to evaluate the safety and efficacy of ProvayBlueTM (methylene blue) for the treatment of acquired methemoglobinemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2023
Price :
$35
*
At a glance
- Drugs Methylthioninium chloride (Primary)
- Indications Methaemoglobinaemia
- Focus Therapeutic Use
- Sponsors Provepharm
- 09 Mar 2021 Status changed from recruiting to completed.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.
- 22 Aug 2017 New trial record